Measurement of Bone Mass by Total Body Calcium: A Review

Lachmann E. Osteoporosis: The potentialities and limitations of its roentgenologic diagnosis. Am J Roentgen 1955; 74: 712–15.

Reifenstein ECJ . Definitions, terminology and classification of metabolic bone disorders. Clin Orthop 1957; 9: 30–44.

Barnett E Nordin BEC . The radiological diagnosis of osteoporosis: A new approach. Clin Radiol 1960; 11: 166–74.

Singh M Nagrath AR Maini PS. Changes in the trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg (Am) 1970; 52: 457–67.

Mazess RB. Non-invasive measurement of bone. In: Barzel US , ed. Osteoporosis II. New York: Grune and Stratton, 1979:5–26.

Virtama P Telkka A. Cortical thickness as an estimate of mineral content of human humerus and femur. Br J Radiol 1962; 35: 632–3.

Meema H Meema S. Measureable roentgenologic changes in some peripheral bones in senile osteoporosis. J Am Geriatr Soc 1963; 11: 1170–82.

Anton HC. Width of clavicular cortex in osteoporosis. Br Med J 1969; i: 409–11.

Recker RR Saville PD Heaney RP. Effects of oestrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 1977; 87: 649–55.

Dequeker J. Problems in measuring the amount of bone: Reproducibility, variability, sequential evaluation. In: Meunier PJ , ed. Bone histomorphometry. Toulouse: Societe Nouvelle Imprime Fourne, 1977:19–37.

Horsman A Simpson M. The measurement of sequential changes in cortical bone geometry. Br J Radiol 1975; 48: 471–6.

Cameron JR Sorensen J. Measurement of bone mineral in vivo: An improved method. Science 1963; 142: 230–2.

Mazess RB. Estimation of bone and skeletal weight by direct photon absorptiometry. Invest Radiol 1971; 6: 52–60.

Vogel JM Anderson JT. Rectilinear transmission scanning of irregular bones for quantification of mineral content. J Nucl Med 1972; 13: 13–18.

West RR Reed GW. The measurement of bone mineral in vivo by photon beam scanning. Br J Radiol 1980; 43: 886–93.

Shimmins J Smith DA Aitken M Anderson JB Gilespie FC. The accuracy and reproducibility of bone mineral measurements ‘in vivo’. Clin Radiol 1972; 23: 47–51.

Ringe JD. Precision and clinical application of peripheral single photon absorptiometry. In: Dequeker J Johnston CC , eds. Non-invasive bone measurements. Oxford: IRL Press, 1982:47–54.

Reed GW. The assessment of bone mineralisation from the relative transmission of ²⁴¹Am and ¹³⁷Cs radiations. Phys Med Biol 1966; 11: 174.

Mazess RB Ort M Judy P Mather W. Absorptiometric bone mineral determination using ¹⁵³Gd. In: Cameron JR , ed. Proceedings of bone measurements conference (Conference 700515). Washington DC: US Atomic Energy Commission, 1970:308–12.

Roos BO Skoldborn H. Dual photon absorptiometry in lumbar vertebrae. Acta Radiol [Ther] 1974; 13: 266–80.

Krolner B Nielsen S Pors . Measurement of bone mineral content of the lumbar spine I. Theory and application of a new two dimensional dual photon attenuation method. Stand J Clin Lab Invest 1980; 40: 653–63.

Genant HK Boyd DP. Quantitative bone mineral analysis using dual-energy computed tomography. Invest Radiol 1977; 12: 545–51.

Peppler WW Mazess RB. Total body bone mineral and lean body mass by dual photon absorptiometry. Calcif Tissue Int 1981; 33: 353–9.

Gotfredsen A Borg J Christiansen C. Total body bone mineral measured by dual photon absorptiometry. Calcif Tissue Int 1983; 35s: A2.

Mazess RB Peppler WW Chestnut CH Nelp WB Cohn SH Zanzi I. Total body bone mineral and lean body mass by dual-photon absorptiometry: IL Comparison with total body calcium by neutron activation analysis. Calcif Tissue Int 1981; 33: 361–3.

Cohn SH Ellis KJ Vartsky D Zanzi I Aloia JF. Medical application of in vivo neutron activation analysis. In: Nuclear activation techniques in the life sciences. Vienna: International Atomic Energy Authority, 1979:1–16.

Weast RC. Handbook of chemistry and physics. Cleveland, Ohio: CRC Press, 1975:B258.

Hansen JW Prussin SG. Precise measurement of the half-life of ⁴⁹Ca. Int J Appl Radial Isot 1970; 21: 335–8.

Dzhelepov BS Pecker LK. Decay schemes of radioactive nucleii. London: Pergamon Press.

Fourman P Royer P. Calcium metabolism and the bone. Oxford: Blackwell, 1968:20.

Catto GRD McIntosh JAR MacLeod M. Partial body neutron activation analysis in vivo: a new approach to the investigation of metabolic bone disease. Phys Med Biol 1973; 18: 508–17.

Smith MA Macpherson JB. Neutron activation analysis by ²⁵²Cf for the estimation of the calcium content in bone. Calcif Tissue Res 1977; 22s: 568–71.

Al-Hiti K Thomas BJ Al-Tikrity SA Ettinger KU Fremlin JH Dabek JT. Spinal calcium: Its in vivo measurement in man. Int J Appl Radiat Isot 1976; 27: 97–102.

Smith MA Tothill P. Development of apparatus to measure calcium changes in the forearm and spine by neutron activation analysis using californium- 252. Phys Med Biol 1979; 24: 319–29.

McNeill KG Thomas JB Sturtridge WC Harrison JE. In vivo neutron activation analysis in man. J Nucl Med 1973; 14: 502–6.

Smith MA. Neutron activation analysis: Choice of site, precision and accuracy. In: Dequeker J Johnston CC , eds. Non-invasive bone measurements. Oxford: IRL Press, 1982:77–84.

Chamberlain MJ Fremlin JH Peters DK Philip H. Total body calcium by whole body neutron activation analysis: A new technique for study of bone disease. Br Med J 1968; ii: 581–3.

Cohn SH Shukla KK Dombrowski CS Fairchild RG. Design and calibration of a ‘broad-beam’ ²³⁸Pu, Be neutron source for total-body neutron activation analysis. J Nucl Med 1972; 13: 487–92.

Cohn SH Dombrowski CS Fairchild RG. In vivo neutron activation analysis of calcium in man. Int J Appl Radiat Isot 1970; 21: 127–37.

Boddy K Holloway I Elliot A. A simple facility for total body in-vivo activation analysis. Int J Appl Radiat Isot 1973; 24: 428–30.

Nelp WB Palmer HE Murano R Measurement of total body calcium (bone mass) in-vivo with use of total body neutron activation analysis. J Lab Clin Med 1970; 76: 151–62.

Spinks TJ Bewley DK. Activation analysis in-vivo of the human body using cyclotron produced neutrons. Proc Anal Div Chem Soc 1976; 13: 204–6.

Smith MA Kennedy NSJ Eastell R Simpson JD Strong JA Tothill P. Absolute measurements of total body calcium by neutron activation analysis. Nucl Med Commun 1980; 1: 166.

Williams ED Boddy K Harvey I Haywood JK. Calibration and evaluation of a system for total body in vivo activation analysis using 14MeV neutrons. Phys Med Biol 1978; 23: 405–15.

Kennedy NSJ Eastell R Ferrington CM Total body neutron activation analysis of calcium: Calibration and normalisation. Phys Med Biol 1982; 27: 697–707.

Tothill P Nicoll J Kennedy NSJ Smith MA Reid DM Nuki G. The in-vivo precision of total body calcium determinations by neutron activation analysis. In: Christiansen C Arnaud CD Nordin BEC Parfitt AM Peck WA Riggs BL , eds. Osteoporosis. Glostrup Hospital, Denmark: Department of Cinical Chemistry, 1984:217–8.

Cohn SH Vaswani A Zanzi I Aloia JF Roginsky MS Ellis KJ. Changes in body chemical composition with age measured by total body neutron activation. Metabolism 1976; 25: 85–95.

Ott SM Murano R Lewellen TK Nelp WB Chestnut CH III Total body calcium by neutron activation analysis in normals and osteoporotic populations: A discriminator of significant bone mass loss. J. Lab Clin Med 1983; 102: 637–45.

Ellis KJ Cohn SH. Correlation between skeletal calcium and muscle mass in man. J Appl Physiol 1975; 38: 455–60.

Smith MA Eastell R Kennedy NSJ The assessment of osteoporosis by total body neutron activation analysis. In: Menczel J Robin GC Makin M Steinberg R , eds. Osteoporosis. Chichester: John Wiley, 1983:109–16.

Eastell R Kennedy NSJ Smith MA Simpson JD Strong JA Tothill P. The assessment of postmenopausal osteoporosis by total body neutron activation analysis. Metab Bone Dis Relat Res 1983; 5: 65–7.

Cohn SH Ellis KJ Wallach S Zanzi I Atkins HL Aloia JF. Absolute and relative deficit in total skeletal calcium and radial bone mineral in osteoporosis. J. Nucl Med 1974; 15: 428–35.

Chestnut CH Nelp WB Lewellen TK. Neutron activation analysis for whole body calcium measurement. In: De Luca HF Frost HM Jee WSS Johnston CC Parfitt AM , eds. Osteoporosis: Recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981:19–23.

Cohn SH Abesami C Yasumura S Aloia JF Zanzi I Ellis KJ. Comparative skeletal mass and radial bone mineral content in black and white women. Metabolism 1977; 26: 171–8.

Wallach S Avramides A Flores A Bellavia J Cohn SH. Skeletal turnover and total body elemental composition during extended calcitonin treatment of Paget's disease. Metabolism 1975; 24: 745–53.

Cohn SH Cinque TJ Dombrowski CS Letteri JM. Determination of body composition by neutron activation analysis in patients with renal failure. J. Lab Clin Med 1972; 79: 978–94.

Denny JD Sherrard DJ Nelp WB Chestnut CH Baylink DJ. Total body calcium and long-term calcium balance in chronic renal disease. J. Lab Clin Med 1973; 82: 226–40.

Cohn SH Roginsky MS Aloia JF Ellis KJ Shukla KK. Alterations in elemental body composition in thyroid disorders. J Clin Endocrinol Metab 1973; 36: 742–9.

Cohn SH Roginsky MS Aloia JF Ellis KJ Shukla KK. Alterations in skeletal calcium and phosphorus in dysfunction of the parathyroids. J Clin Endocrinol Metab 1973; 36: 750–5.

Aloia JF Petrak Z Ellis K Cohn SH. Body composition and skeletal metabolism following pituitary radiation in acromegaly. Am J Med 1976; 61: 59–73.

Tothill P Nicoll J Kennedy NSJ Smith MA Reid DM Nuki G. The lack of seasonal variation of total body calcium. In: Christiansen C Arnaud CD Nordin BEC Parfitt AM Peck WA Riggs BL , eds. Osteoporosis. Glostrup Hospital, Denmark: Department of Clinical Chemistry, 1984:815–17.

Reid DM Kennedy NSJ Smith MA Tothill P Nuki G. Bone mass in primary generalised osteoarthrosis. Ann Rheum Dis 1984; 43: 240–2.

Reid DM Kennedy NSJ Smith MA Tothill P Nuki G. Total body calcium in rheumatoid arthritis: Effects of disease activity and corticosteroid therapy. Br Med J 1982; 285: 330–2.

Reid DM Nicoll J Brown N Bone mass in rheumatoid arthritis, polymyalgia rheumatica and asthma: Disease determines susceptibility to corticosteroid induced osteoporosis. In: Christiansen C Arnaud CD Nordin BEC Parfitt AM Peck WA Riggs BL , eds. Osteoporosis. Glostrup Hospital, Denmark: Department of Clinical Chemistry, 1984:811–13.

Reid DM Nicoll J Brown N Smith MA Tothill P Nuki G. Bone mass in corticosteroid treated patients with rheumatoid arthritis, asthma and polymyalgia rheumatica. Scot Med J 1985; 30: 54–5.

Wallach S Cohn SH Atkins HL Effect of salmon calcitonin on skeletal mass in osteoporosis. Curr Ther Res 1977; 22: 556–61.

Chestnut CH Baylink DJ Gruber HE Treatment of postmenopausal osteoporosis with salmon calcitonin: Preliminary results. In: De Luca HF Frost HM Jee WSS Johnston CC Parfitt AM , eds. Osteoporosis: Recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981:411–18.

Chestnut CH Sisom K Nelp WB Are synthetic salmon calcitonin and anabolic steroids efficacious in the treatment of post-menopausal osteoporosis? In: Dixon AStJ Russell RGG Stamp TCB , eds. Osteoporosis. A multi-disciplinary problem. London: Academic Press and Royal Society of Medicine, 1983:239–43 (Royal Society of Medicine International Congress and Symposium Series No. 55).

Chestnut CH Nelp WB Baylink DJ Denney DJ. Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass. Metabolism 1977; 26: 267–77.

Chestnut CH. Treatment of post-menopausal osteoporosis: Some current concepts. Scot Med J 1981; 26: 72–80.

Aloia JF Kapoor A Vaswani A Cohn SH. Changes in body composition following therapy of osteoporosis with methandrostenolone. Metabolism 1981; 30: 1076–9.

Reid DM Nicoll J Brown N Bone loss in rheumatoid arthritis (RA) and primary generalised osteoarthrosis (PGOA). Br J Rheumatol 1984; 23: 116–17.